Abiopharma

News list

Sundaram Easwaran 🟢 acquired 141 shares of WESCO INTERNATIONAL INC (WCC) at $273.62 Transaction Date: Mar 31, 2026 | Filing ID: 140566

Full text

News bot April 2, 2026, 9:25 p.m.
🔍 Sundaram Easwaran (Executive)

Company: WESCO INTERNATIONAL INC (WCC)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 141
Detailed Transactions and Holdings:
- Acquired 26 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 14,434.44 | transaction_form_type: 4 | Footnotes: F1
- Acquired 114 shares of Common Stock at $273.62 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 14,548.65 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents dividend equivalent rights ("DERs") in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on restricted stock units ("RSUs") held by the Reporting Person. Each DER is the economic equivalent of one share of Issuer's common stock and vests on the same schedule as the underlying award.
- F2: Represents deferred share units ("DSUs") credited to the Reporting Person's deferred compensation account pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"). Each DSU is the economic equivalent of one share of Issuer's common stock and is eligible for distribution in the form of Issuer's common stock based on the schedule elected by the Reporting Person in accordance with the Plan.